China approved human trial of two COVID-19 vaccines China has approved the start of clinical trials of two inactivated vaccines against the new coronavirus pneumonia COVID-19.As it became known on Tuesday, thanks to the mechanism of joint prevention and control of COVID-19 at the State Council of China, vaccines were developed by the Wuhan Institute of Biological Products under the Chinese State Pharmaceutical Corporation Sinopharm and the Beijin...

Please login or subscribe to read more

Leave a review

In World

Follow us on social networks

In Focus